Dose‐Related Safety and Immunogenicity of Baculovirus‐Expressed Trivalent Influenza Vaccine: A Double‐Blind, Controlled Trial in Adult Patients with Non‐Hodgkin B Cell Lymphoma
Open Access
- 15 November 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 194 (10) , 1394-1397
- https://doi.org/10.1086/508493
Abstract
In 27 patients randomized to receive commercial trivalent influenza vaccine (TIV) containing 15 μg of the hemagglutinin (HA) of influenza A (H3N2 andKeywords
This publication has 0 references indexed in Scilit: